ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Retention of apolipoprotein (apo)B and apoE-containing lipoproteins by extracellular vascular proteoglycans is critical in atherogenesis. Moreover, high circulating apoC-III levels are associated with increased atherosclerosis risk. To test whether apoC-III content of apoB-containing lipoproteins affects their ability to bind to the vascular proteoglycan biglycan, we evaluated the impact of apoC-III on the interaction of [(35)S]SO(4)-biglycan derived from cultured arterial smooth muscle cells with lipoproteins obtained from individuals across a spectrum of lipid concentrations. The extent of biglycan binding correlated positively with apoC-III levels within VLDL (r = 0.78, P < 0.01), IDL (r = 0.67, P < 0.01), and LDL (r = 0.52, P < 0.05). Moreover, the biglycan binding of VLDL, IDL, and LDL was reduced after depletion of apoC-III-containing lipoprotein particles in plasma by anti-apoC-III immunoaffinity chromatography. Since apoC-III does not bind biglycan directly, enhanced biglycan binding may result from a conformational change associated with increased apo C-III content by which apoB and/or apoE become more accessible to proteoglycans. This may be an intrinsic property of lipoproteins, since exogenous apoC-III enrichment of LDL and VLDL did not increase binding. ApoC-III content may thus be a marker for lipoproteins characterized as having an increased ability to bind proteoglycans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1 LDL binds to biglycan with high affinity. A: Autoradiograph of a gel from the electrophoretic gel mobility shift assay is shown. Increasing concentrations of VLDL, IDL, and LDL from a subject were incubated with a fixed amount (0.19 𝛍 M) of [ 35 S]SO4-labeled biglycan for 1 h at 37 ° C prior to electrophoresis in agarose, as described in Materials and Methods. Biglycan that binds lipoproteins remains at the origin, or migrates a short distance into the gel. Free, unbound [ 35 S]SO4-biglycan migrates to the front of the gel. B: The binding curves for the interaction of VLDL (circle), IDL (square), and LDL (triangle) and [ 35 S]SO4-labeled biglycan that were shown in A. The amount of bound versus free [ 35 S]SO4-biglycan for each lane was calculated, and plotted against the concentration of total protein for that lipoprotein sample. The inset shows the same data as a Scatchard plot. Data are from a single experiment that is representative of lipoprotein samples from 24 subjects.](https://figures.cochat.ai/paper-figures/47acf12c2c17455b9e5b69f9a1c02a91/apoc-iii-content-of-apob-containing-lipoproteins-is-associated-with-binding-to-figure-1.png)
![Fig. 2 Within each lipoprotein class, the amount of apoC-III correlates positively with the ability of the lipoprotein to bind biglycan. Hyperbolic regression curves are shown to demonstrate the correlation of a lipoprotein's apoC-III content with the amount of biglycan bound to samples of lipoprotein (VLDL, circle; IDL, square; LDL, triangle) that contained 0.05 mg/ml total protein. For the interaction, samples were incubated with a fixed amount (0.19 𝛍 M) of [ 35 S]SO4-labeled biglycan for 1 h at 37 ° C prior to electrophoresis in agarose, as described in Materials and Methods.](https://figures.cochat.ai/paper-figures/6d564be98af9412eabaaf31603a5bd49/apoc-iii-content-of-apob-containing-lipoproteins-is-associated-with-binding-to-figure-2.png)
![Fig. 3 Within each lipoprotein class, the amount of apoC-III correlates with the affinity constant ( Ka ) for the interaction of the lipoprotein with biglycan. Hyperbolic regression curves are shown to demonstrate the correlation of a lipoprotein's apoC-III content with the affinity constant ( Ka ) calculated from the interaction with biglycan (VLDL, circle; IDL, square; LDL, triangle). For the interaction, samples were incubated with a fixed amount (0.19 𝛍 M) of [ 35 S]SO4-labeled biglycan for 1 h at 37 ° C prior to electrophoresis in agarose, as described in Materials and Methods.](https://figures.cochat.ai/paper-figures/1d4dc0f8e7f64d03bb874756cda7f58a/apoc-iii-content-of-apob-containing-lipoproteins-is-associated-with-binding-to-figure-3.png)
![Fig. 4 Increased binding of biglycan to lipoproteins that contain apoC-III compared to apoC-III-depleted lipoproteins. Binding curves are shown for the interaction of biglycan and apoC-III-containing (A) VLDL, (B) IDL, and (C) LDL (open circle), or VLDL, IDL, and LDL isolated from the same plasma sample that had been passed over an anti-human apoC-III column (closed circle). Equal numbers of lipoprotein particles were incubated with a fixed amount (0.19 𝛍 M) of [ 35 S]SO4-labeled biglycan for 1 h at 37 ° C prior to electrophoresis in agarose, as described in Materials and Methods. The insets show the same data as Scatchard plots. The data are from a single experiment that is representative of two independent experiments.](https://figures.cochat.ai/paper-figures/68456f2f4ec547ad8bf3dfad19e053f3/apoc-iii-content-of-apob-containing-lipoproteins-is-associated-with-binding-to-figure-4.png)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“VLDL and remnants are also enriched in apoE and apoCIII, both implicated in binding and retention in the artery wall.5,71,125”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331 · cited 1×
“LDL protein concentrations were determined by a modification of the method of Lowry, et al. ( 25 ) using BSA as the standard.”
MethodPhosphorus Assay in Column Chromatography
Bartlett, G. R. (1959) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)70226-3 · Cited by 12,801 · cited 1×
“Phospholipids were measured using a standardized colorimetric method (24) and a phosphorous calibrator (Sigma Chem.”
MethodThe Response-to-Retention Hypothesis of Early Atherogenesis
Williams, K. J., & Tabas, I. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.5.551 · Cited by 1,413 · cited 1×
“Kinetic analyses suggest that the trapping of lipoproteins by arterial wall proteoglycans is due to selective retention rather than increased delivery of the lipoproteins (4, 8).”
BackgroundMolecular modeling of protein-glycosaminoglycan interactions.
Cardin, A. D., & Weintraub, H. J. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.1.21 · Cited by 1,301 · cited 3×
“This is consistent with the presence of heparin/proteoglycan binding regions on both apoB and apoE (5, 36 ).”
BackgroundResultInfluentialFisher, L. W., Termine, J. D., & Young, M. F. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83781-4 · Cited by 702
Mahley, R. W., & Ji, Z.-S. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33334-4 · Cited by 693
Blood Lipids and Lipoproteins: Quantitation, Composition and Metabolism
(1973) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1973.tb128705.x · Cited by 554
Chait, A., Brazg, R. L., Tribble, D. L., & Krauss, R. M. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90144-e · Cited by 554 · cited 1×
“Along with being more susceptible to oxidative modification than large LDL (50, 51), small, dense LDL particles have been hypothesized to have greater permeability and have been suggested to have enhanced affinity for arterial wall proteoglycans (7, 52).”
BackgroundSelf-citation[24] Nondenaturing polyacrylamide gradient gel electrophoresis
Nichols, A. V., Krauss, R. M., & Musliner, T. A. (1986) · Methods in Enzymology · doi:10.1016/0076-6879(86)28084-2 · Cited by 521 · cited 1×
“Particle size measurement of apoB-containing lipoproteins was performed on plasma and isolated lipoprotein fractions using non-denaturing 2–14% polyacrylamide gradient gel electrophoresis (GGE) and standardized conditions (23).”
MethodSelf-citationSuperoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells.
Heinecke, J. W., Baker, L., Rosen, H., & Chait, A. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112371 · Cited by 517
Self-citation
Cited by
Borén, J., Chapman, M. J., Krauss, R. M., Packard, C. J., Bentzon, J. F., Binder, C. J., Daemen, M. J., Demer, L. L., Hegele, R. A., Nicholls, S. J., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz962 · Cited by 1,601
Self-citationGinsberg, H. N., Packard, C. J., Chapman, M. J., Borén, J., Aguilar-Salinas, C. A., Averna, M., Ference, B. A., Gaudet, D., Hegele, R. A., Kersten, S., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab551 · Cited by 979
“in apoE and apoCIII, both implicated in binding and retention in the artery wall.(5,71,125) These factors enhance remnant cholesterol deposition in the plaque;(71,126,127) indeed, unlike LDL, remnant particle entry exceeds efflux.”
BackgroundBorén, J., & Williams, K. J. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000330 · Cited by 524
“The mechanism has been unclear because apoC-III by itself lacks positively charged domains to bind arterial-wall proteoglycans [51].”
BackgroundNakashima, Y., Wight, T. N., & Sueishi, K. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn099 · Cited by 299
“LDL, very-low-density lipoprotein (VLDL), and intermediatedensity lipoprotein (IDL).(73) Overexpression of human biglycan by rat SMCs results in production of an ECM with increased high-affinity lipoprotein binding.”
BackgroundSelf-citationApolipoproteins in vascular biology and atherosclerotic disease
Mehta, A., & Shapiro, M. D. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00613-5 · Cited by 273
Metadata
- Authors
- Olin-Lewis, K., Krauss, R. M., La Belle, M., Blanche, P. J., Barrett, P. H. R., Wight, T. N., & Chait, A.
- Affiliations
- Lawrence Berkeley National Laboratory (US)
- The University of Western Australia (AU)
- University of Washington (US)
- Corresponding author
- Chait, Alan
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2002-11
- Volume
- 43
- Issue
- 11
- Pages
- 1969-1977
- ISSN
- 0022-2275 (ISSN-L)
- OpenAlex
- W2015816213
- Cited by
- 114
- References
- 54
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 10 · 2023: 6 · 2022: 4 · 2021: 7 · 2020: 10 · 2019: 2 · 2018: 5 · 2017: 1 · 2016: 7 · 2015: 3 · 2014: 3 · 2013: 2 · 2012: 6
- FWCI
- 4.14
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6514 d)
- Locations
- Journal of Lipid Research (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (HL30086)
- U.S. Public Health Service (12609)
- National Heart, Lung, and Blood Institute (P01HL030086, HL3-0086, HL 18754)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 02456, DK35816-16, P30DK035816)
- National Center for Research Resources
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Keywords
- apolipoprotein C-III, biglycan, apolipoprotein B, apolipoprotein E, VLDL, IDL, low-density lipoprotein, atherosclerosis, atherogenesis, arterial smooth muscle cells, immunoaffinity chromatography
- MeSH terms
- Apolipoproteins B, Apolipoproteins C, Chromatography, Affinity, Humans, Lipoproteins, Lipoproteins, LDL, Lipoproteins, VLDL, Particle Size, Proteoglycans, Extracellular Matrix Proteins, Apolipoprotein C-III, Biglycan
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan. https://app.cochat.ai/papers/10.1194/jlr.m200322-jlr200
- The paper
- Olin-Lewis, K., Krauss, R. M., La Belle, M., Blanche, P. J., Barrett, P. H. R., Wight, T. N., & Chait, A. (2002). ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan. Journal of Lipid Research. https://doi.org/10.1194/jlr.m200322-jlr200
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.